The Trump administration may take a stake in Lithium Americas, Syensqo reopens a synthetic vanillin plant, Genmab inks $8 billion deal for Merus, and more.

A group of RNA veterans is launching a new start-up aimed at getting RNA-interfering (RNAi) molecules into the brain to silence the genes that cause neurodegenerative diseases. Called Aerska, the ...

A simple one-step process recovers more than 90% of rare earth elements (REEs) from magnets ( Proc. Natl. Acad. Sci. U.S.A. 2025, DOI: 10.1073/pnas.2507819122).

The aurora borealis is a spectacle of space weather, but solar flares and coronal mass ejections have far more Earthly ...

The acquisition will mark Pfizer’s reentry into the weight-loss market after the failure of its GLP-1 drug candidate ...

The agency proposes to undo several aspects of a major US chemical law, including the definition of ‘weight of scientific ...

Using historical data, the MIT team concluded that a 40% reduction in funding over the past 45 years would have affected more than 50% of new drug approvals since 2000.

The details vary, but the House and the Senate could spare the NSF, NIH, and other science agencies from drastic budget reductions ...

The panel elected not to recommend a combination vaccine for measles, mumps and rubella as well as varicella, also known as ...

A National Academies of Sciences, Engineering, and Medicine study released Wednesday says evidence that GHG emissions harm ...

Brianna: Sure. It’s about sort of the current state of this fast-growing subfield of organic chemistry known as skeletal ...

The Donald J. Trump administration said Monday it has identified a link between taking acetaminophen —often referred to by the brand name Tylenol in the US—during pregnancy and an increased chance ...